We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the prevalence, risk factors, symptoms, and importance of early detection for kidney cancer. Understand your risks and when to seek medical advice.
What is Kidney Cancer? Kidney cancer is a significant health concern, ranking among the top 10 most common cancers in the United States and the 14th most common globally. While it may not be as widely discussed as some other cancers, its prevalence affects hundreds of thousands of people. Understanding the statistics, risk factors, and potential symptoms is crucial for early detection and better outcomes. This article aims to provide a comprehensive overview of kidney cancer, tailored for an Indian audience, covering its commonality, who is most at risk, and the importance of timely medical consultation. How Common is Kidney Cancer? In the United States, kidney cancer is a notable concern. The American Cancer Society (ACS) estimated that in 2023, approximately 81,800 new cases of kidney cancer would be diagnosed. More broadly, in 2020, the National Cancer Institute (NCI) reported that over 600,000 people in the U.S. were living with this diagnosis. The incidence rate in the U.S. is significantly higher than the global average, more than doubling it, which places the U.S. seventh highest in the world for kidney cancer rates. While these statistics are from the U.S., they highlight the global impact and the need for awareness everywhere. Who is Most at Risk for Kidney Cancer? Several factors can influence an individual's risk of developing kidney cancer. While it can affect people of all ages, the risk generally increases with age, particularly up to age 75. The majority of diagnoses, around 70%, occur in individuals between the ages of 45 and 74, with the peak incidence seen in those aged 65 to 74. However, it's important to note that kidney cancer can occur in younger individuals, with only about 8.6% of new diagnoses happening in those under 45. Demographic Factors: Race and Ethnicity: In the U.S., kidney cancer is more common among Black individuals compared to other racial groups. While the exact reasons are not fully understood, it may be linked to higher rates of known risk factors within this population. American Indian and Alaska Native populations also show higher rates, whereas Non-Hispanic Asians and Pacific Islanders tend to have the lowest rates. Gender: Individuals assigned male at birth are about twice as likely to develop kidney cancer as those assigned female at birth. The reasons for this disparity are still being researched but could involve genetic, hormonal, or lifestyle factors. Transgender Individuals: Research indicates that kidney cancer may affect transgender individuals at a rate of about 4.1%. While this is slightly lower than cisgender males (4.8%), it is higher than cisgender females (2.7%). Studies also suggest that transgender individuals might face delays in receiving timely medical care, which can impact outcomes. Genetic and Family History: Inherited Conditions: Certain genetic conditions, such as von Hippel-Lindau disease, significantly increase the risk of kidney cancer. Family History: Having a close relative, especially a sibling, with kidney cancer can also elevate your risk. It remains unclear whether this is primarily due to shared genetics, environmental factors, or a combination of both. Lifestyle and Environmental Factors: Several controllable factors can influence your risk: Smoking: Smoking tobacco is a major risk factor for kidney cancer. Obesity: Being overweight or obese increases the likelihood of developing kidney cancer. High Blood Pressure (Hypertension): Chronic high blood pressure is linked to an increased risk. Occupational Exposures: Exposure to certain chemicals, such as cadmium, asbestos, and some pesticides, in the workplace can elevate risk. Certain Medications: Long-term use of some pain relievers, particularly those containing phenacetin, has been associated with increased risk. Kidney Disease: Individuals with certain chronic kidney diseases may have a higher risk. Symptoms of Kidney Cancer One of the challenges with kidney cancer is that, in its early stages, it often presents with no noticeable symptoms. This is why regular health check-ups are vital, especially for those with risk factors. When symptoms do appear, they can be indicative of more advanced disease and may include: Blood in the urine (hematuria): This can appear as pink, red, or cola-colored urine. A persistent lump or mass on the side or lower back: This may be felt externally. Pain in the side, lower back, or abdomen: This pain can be persistent and severe. Fatigue or unexplained tiredness. Loss of appetite. Unexplained weight loss. Fever that is not caused by an infection. Anemia (low red blood cell count). It is crucial to remember that these symptoms can also be caused by many other, less serious conditions. Therefore, consulting a doctor to determine the exact cause is essential. Diagnosis of Kidney Cancer Diagnosing kidney cancer typically involves a combination of medical history, physical examination, and various tests: Imaging Tests: CT scans, MRI scans, and ultrasounds are commonly used to visualize the kidneys and detect tumors. Biopsy: In some cases, a small sample of kidney tissue may be taken and examined under a microscope to confirm the diagnosis and determine the type of cancer. Blood and Urine Tests: These can help assess kidney function and detect abnormalities like blood in the urine. Treatment and Outlook The treatment approach for kidney cancer depends on several factors, including the stage of the cancer, the type of kidney cancer (renal cell carcinoma, or RCC, being the most common), the patient's overall health, and their preferences. Treatment options may include surgery to remove the tumor, targeted therapy, immunotherapy, radiation therapy, or chemotherapy. The outlook for kidney cancer, often referred to as prognosis, is generally
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.

Discover 3 subtle signs of mouth cancer often dismissed as minor issues. Learn why early detection is crucial for effective treatment.
April 23, 2026
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026